BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14100088)

  • 1. SERUM COMPLEMENT LEVELS IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA.
    MILLER JN; MEYERS RL; CARPENTER CM
    J Pediatr; 1964 Jan; 64():134-7. PubMed ID: 14100088
    [No Abstract]   [Full Text] [Related]  

  • 2. FURTHER OBSERVATION ON THE ROLE OF ANEUPLOIDY IN ACUTE LEUKEMIA.
    REISMAN LE; ZUELZER WW; THOMPSON RI
    Cancer Res; 1964 Sep; 24():1448-55. PubMed ID: 14221801
    [No Abstract]   [Full Text] [Related]  

  • 3. INTRACRANIAL EXTRACEREBRAL HEMORRHAGES IN ACUTE LYMPHOCYTIC LEUKEMIA. A PROBLEM RESULTING FROM THE CHEMOTHERAPEUTIC MODIFICATIONS OF ACUTE LEUKEMIA.
    BELMUSTO L; REGELSON W; OWENS G; HANANIAN J; NIGOGOSYAN G
    Cancer; 1964 Aug; 17():1079-88. PubMed ID: 14202596
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of "total therapy" of acute lymphocytic leukemia in children.
    George P; Hernandez K; Hustu O; Borella L; Holton C; Pinkel D
    J Pediatr; 1968 Mar; 72(3):399-408. PubMed ID: 5237796
    [No Abstract]   [Full Text] [Related]  

  • 5. CHEMOTHERAPY OF ACUTE LEUKEMIA.
    FREI E
    CA Cancer J Clin; 1964; 14():252-6. PubMed ID: 14216115
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
    Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
    Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [LONG-TERM REMISSIONS OF ACUTE LEUKEMIAS IN CHILDHOOD].
    GASSER C
    Med Klin; 1964 Mar; 59():385-93. PubMed ID: 14176488
    [No Abstract]   [Full Text] [Related]  

  • 8. CHROMOSOME STUDIES IN LEUKEMIA. I. EVIDENCE FOR THE ORIGIN OF LEUKEMIC STEM LINES FROM ANEUPLOID MUTANTS.
    REISMAN LE; MITANI M; ZUELZER WW
    N Engl J Med; 1964 Mar; 270():591-7. PubMed ID: 14096878
    [No Abstract]   [Full Text] [Related]  

  • 9. [STUDY OF FACTORS INFLUENCING SURVIVAL IN ACUTE LEUKEMIAS].
    BERNARD J; BOIRON M; MANUS A; LEVY JP; BRIERE J; DUMONT J
    Schweiz Med Wochenschr; 1964 May; 94():709-14. PubMed ID: 14235201
    [No Abstract]   [Full Text] [Related]  

  • 10. Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia.
    Dervieux T; Hancock ML; Pui CH; Rivera GK; Sandlund JT; Ribeiro RC; Boyett J; Evans WE; Relling MV
    Clin Pharmacol Ther; 2003 Jun; 73(6):506-16. PubMed ID: 12811360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of LC-MS/MS assay for the simultaneous determination of methotrexate, 6-mercaptopurine and its active metabolite 6-thioguanine in plasma of children with acute lymphoblastic leukemia: Correlation with genetic polymorphism.
    Al-Ghobashy MA; Hassan SA; Abdelaziz DH; Elhosseiny NM; Sabry NA; Attia AS; El-Sayed MH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():88-94. PubMed ID: 27802917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of acute leukemia. Opinion of Prof. Franco Mandelli].
    Salvati A
    Minerva Med; 1973 Jan; 64(4):170-2. PubMed ID: 4510268
    [No Abstract]   [Full Text] [Related]  

  • 13. THE CORRELATION BETWEEN TRANSPLANTED MOUSE AND HUMAN ACUTE LEUKEMIAS.
    BURCHENAL JH; OETTGEN HF; LYMAN M; PURPLE J
    Acta Unio Int Contra Cancrum; 1964; 20():256-9. PubMed ID: 14151900
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of methotrexate polyglutamates on thioguanine nucleotide concentrations during continuation therapy of acute lymphoblastic leukemia with mercaptopurine.
    Dervieux T; Hancock M; Evans W; Pui CH; Relling MV
    Leukemia; 2002 Feb; 16(2):209-12. PubMed ID: 11840287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
    Paśnicki M
    Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
    [No Abstract]   [Full Text] [Related]  

  • 16. [Our experience with the treatment of juvenile acute leukemia].
    Amici A; Romizi S; De Benedictis FM; Castellucci G; Fracassini F
    Minerva Pediatr; 1977 Nov; 29(37):2285-92. PubMed ID: 271762
    [No Abstract]   [Full Text] [Related]  

  • 17. MORPHOLOGIC ABNORMALITIES OF BONE MARROW CELLS INDUCED BY CHEMOTHERAPEUTIC AGENTS DURING TREATMENT OF LEUKEMIA.
    KUNDEL DW; NIES BA
    Am J Clin Pathol; 1965 Aug; 44():146-54. PubMed ID: 14323486
    [No Abstract]   [Full Text] [Related]  

  • 18. [Present status of therapy of acute leukemia].
    Polli E
    Haematol Lat; 1969; 12(3):783-98. PubMed ID: 5273185
    [No Abstract]   [Full Text] [Related]  

  • 19. THE TREATMENT OF LEUKEMIA.
    WILTSHAW E
    N Engl J Med; 1964 Mar; 270():570-2. PubMed ID: 14091531
    [No Abstract]   [Full Text] [Related]  

  • 20. Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience.
    Cassileth PA; Andersen JW; Bennett JM; Hoagland HC; Mazza JJ; O'Connell MC; Paietta E; Wiernik P
    Leukemia; 1992; 6 Suppl 2():178-81. PubMed ID: 1578927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.